15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Solventum Corp, 6 rate it Buy or better, 4 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $60.00 to $100.00, a moderate spread. The average target of $84.27 sits 2% below the current $86.21. The rating mix has stayed broadly stable, with Buy-side ratings easing from 7 to 6 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.41 next quarter toward $7.09 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy655%
Hold436%
Sell19%
Strong Sell00%
Based on 11 analysts giving stock ratings to Solventum Corp.
As of Jul, 6 of 11 firms rate SOLV a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
SOLV EPS & revenue forecast
EPS · NEXT QUARTER
$1.41
Range $1.35 – $1.48 · 12 analysts · -6% YoY
Next period, 12 analysts expect Solventum Corp. to earn $1.41 a share (range $1.35 – $1.48), versus $1.50 a year earlier. Full-year consensus is $6.55, growing to $7.09 the year after.
REVENUE · NEXT QUARTER
$2.0B
Range $2.0B – $2.0B · 12 analysts · -6% YoY
Revenue is expected to reach $2.0B (range $2.0B – $2.0B), -6.3% year-over-year. Full-year consensus is $8.2B, rising to $8.5B next year.
Top analysts covering Solventum Corp.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SOLV.
#1
Jason Bednar
Piper Sandler · Rank #303
Buy
$92.00+6.7% to target
Overall win rate
33%
+ Follow
#2
Brett Fishbin
KeyBanc
Buy
$93.00+7.9% to target
Coverage
—
+ Follow
#3
Kevin Caliendo
UBS
Hold
$78.00-9.5% to target
Coverage
—
+ Follow
#4
Ryan Zimmerman
BTIG
Buy
$89.00+3.2% to target
Coverage
—
+ Follow
#5
VC
Vik Chopra
Wells Fargo
Hold
$70.00-18.8% to target
Coverage
—
+ Follow
SOLV stock forecast FAQ
What is SOLV's average 12-month price target?+
The 10 analysts with a live target average $84.27 for Solventum Corp. over the next 12 months, ranging from a $100.00 high to a $60.00 low.
Is SOLV stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 6 are Buy or Strong Buy, 4 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for SOLV?+
The Street-high target is $100.00 (Mizuho), and the Street-low is $60.00 (Rothschild & Co). The average of all 10 active targets is $84.27.
How many Wall Street analysts cover SOLV?+
11 analysts have an active rating on Solventum Corp., and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering SOLV?+
Among analysts who currently cover SOLV, Jason Bednar of Piper Sandler has the strongest overall Quantellect track record (Rank #303). Their current call is Buy with a $92.00 target.
What is Solventum Corp.'s projected EPS for next quarter?+
The consensus estimate is $1.41 per share (range $1.35 – $1.48) across 12 analysts. Full-year EPS is projected at $6.55, rising to $7.09 the following year.
How much revenue is Solventum Corp. expected to report next quarter?+
Consensus revenue is $2.0B (range $2.0B – $2.0B). Full-year revenue is projected at $8.2B, growing to $8.5B next year.
Have analysts been upgrading or downgrading SOLV lately?+
As of Jul, 6 of 11 firms rate SOLV a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SOLV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
